Latest News on UNH

Financial News Based On Company


Advertisement
Advertisement

The Cigna Group Deepens Community Impact Strategy, Adds New Commitment Supporting People with Complex Health Conditions

https://www.streetinsider.com/PRNewswire/The+Cigna+Group+Deepens+Community+Impact+Strategy%2C+Adds+New+Commitment+Supporting+People+with+Complex+Health+Conditions/27375911.html
The Cigna Group has expanded its community impact strategy with a new three-year, $31.5 million commitment from The Cigna Group Foundation. This initiative focuses on youth mental health, veteran well-being, and supporting individuals with complex health conditions and their caregivers, combining grant funding with employee volunteerism. Nonprofits in ten states can apply for grants, with an initial focus on autoimmune, inflammatory, blood, cancer, neurological, and rare diseases.

Health Insurers Sink on Sanders’ Medicare for All Plan

https://www.bloomberg.com/news/articles/2026-11-19/health-insurers-sink-on-sanders-medicare-for-all-plan
US health insurance stocks experienced a significant downturn following announcements of new federal audits for Medicare and Senator Bernie Sanders' proposals for expanded Medicare eligibility. UnitedHealth Group Inc., the largest insurer, saw its shares drop by as much as 21%, wiping out almost all its year-to-date gains due to these developments.

Earnings call transcript: Williams-Sonoma Q3 2026 beats EPS, stock falls 12%

https://www.investing.com/news/transcripts/earnings-call-transcript-williamssonoma-q3-2026-beats-eps-stock-falls-12-93CH-5039588
Williams-Sonoma reported a slight earnings beat for its fiscal third quarter of 2026, with adjusted EPS of $2.19 against an estimated $2.18, though revenue of $1.99 billion fell short of the $2.0 billion forecast. Despite a 5.1% rise in comparable brand revenue and expanded operating margin, the stock dropped over 12% in premarket trading, indicating investor concern over the revenue miss, cost pressures, and the company's outlook. Management reaffirmed full-year fiscal 2026 guidance and discussed strategies like increased full-price selling and the use of AI, while acknowledging challenges from a weak housing market and higher transportation costs.

VA raised Oracle’s contract cap to $27B. Auditors still can’t verify the cost of the rollout.

https://www.militarytimes.com/news/pentagon-congress/2026/11/19/va-raised-oracles-contract-cap-to-27b-auditors-still-cant-verify-the-cost-of-the-rollout/
The Department of Veterans Affairs increased Oracle's electronic health record contract ceiling by $17 billion to $27 billion, with plans to accelerate system deployment in 2027. Despite this, federal auditors from the Government Accountability Office still lack the necessary documentation to verify the total project cost, estimated at $56.5 billion, or confirm if the 2031 completion date is feasible. Concerns persist regarding inflation assumptions, undefined work scope, and the significant increase in contract value compared to similar large-scale health system implementations.

3 ETFs That Hold AstraZeneca In Very Different Ways

https://simplywall.st/etfs/us/nysearca-ewu/news/3-etfs-that-hold-astrazeneca-in-very-different-ways
AstraZeneca's recent cancer treatment approval and high debt levels raise questions about its role in diversified portfolios. This article examines three ETFs—iShares MSCI United Kingdom ETF (EWU), Roundhill GLP-1 & Weight Loss ETF (OZEM), and JPMorgan Healthcare Leaders ETF (JDOC)—that hold AstraZeneca, each offering a different approach to balancing company-specific risks with broader market or sector exposure. Investors can choose between a broad UK market mix, a concentrated weight-loss drug focus, or a global healthcare industry spread.
Advertisement

Medicare Annual Enrollment Halftime Report: 75% of enrollees have used AI tools to review 2027 Medicare plans

https://uk.finance.yahoo.com/news/medicare-annual-enrollment-halftime-report-140000337.html
A new eHealth report reveals that 75% of Medicare beneficiaries who reviewed their 2027 plan options utilized AI tools, although licensed insurance agents remain the primary choice for plan selection. The report also highlights a significant increase in Medicare Advantage plans offered by eHealth covering GLP-1 drugs for obesity and growing optimism about healthcare affordability post-mid-term elections, despite concerns about rising premiums and out-of-pocket costs.

93% of private Medicare plans offered by eHealth cover a drug for obesity in 2027, if patients qualify; 5% did in 2026.

https://www.stocktitan.net/news/EHTH/medicare-annual-enrollment-halftime-report-75-of-enrollees-have-used-fonfcd4e7lml.html
A new eHealth report reveals that 75% of Medicare beneficiaries used AI tools to review their 2027 plan options. Notably, 93% of eHealth's 2027 Medicare Advantage plans now cover at least one GLP-1 drug for obesity, a significant increase from 5% in 2026. Despite technological assistance, cost remains a concern, with 63% of beneficiaries surprised by high monthly premiums and an 8% increase in average out-of-pocket maximums for selected plans.

Modular Medical Secures Coverage Agreements with All Three of the Nation's Largest PBMs for Pivot Insulin Delivery System

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/modular-medical-secures-coverage-agreements-with-all-three-of-the-nat-1253503
Modular Medical, Inc. announced agreements with the remaining two of the nation's three largest pharmacy benefit managers (PBMs) for its Pivot™ tubeless patch pump, establishing broad coverage across commercial, Medicare, and Medicaid plans. These agreements, which cover over 182 million lives and approximately 80% of U.S. prescription claims, are a significant milestone for the company's full commercial launch and aim to increase patient access and affordability for insulin pump therapy. The company believes this will help reduce traditional coverage barriers and support the transition from multiple daily injections to advanced pump therapy.

Buy 3 Blue-Chip Stocks Amid Solid Upside Despite Dow's Recent Debacle

https://www.tradingview.com/news/zacks:9af56b2e1094b:0-buy-3-blue-chip-stocks-amid-solid-upside-despite-dow-s-recent-debacle/
Despite recent volatility in the Dow, three blue-chip stocks—Cisco Systems Inc. (CSCO), UnitedHealth Group Inc. (UNH), and Salesforce Inc. (CRM)—are recommended for their strong guidance, favorable Zacks Rank, and solid price upside potential. Each company has provided robust financial outlooks and positive estimate revisions, with analysts projecting significant gains from their current stock prices.

Does Procter & Gamble (PG) Have A Holiday Hit In Limited Edition Grooming?

https://simplywall.st/stocks/us/household/nyse-pg/procter-gamble/news/does-procter-gamble-pg-have-a-holiday-hit-in-limited-edition
Procter & Gamble (NYSE:PG) has launched the Old Spice Holidudes Collection, a limited-edition seasonal line of men's grooming products with holiday-themed scents. This move allows P&G to test holiday demand and gather real-world data on consumer preferences and gifting behavior. The initiative supports P&G's broader strategy of focusing on product innovation, targeted offerings, and maintaining brand strength through organic sales quality.
Advertisement

Universal Electronics director Satjiv Chahil sells $703,700 in shares

https://www.investing.com/news/insider-trading-news/universal-electronics-director-satjiv-chahil-sells-703700-in-shares-93CH-5038143
Satjiv S. Chahil, a director at Universal Electronics Inc. (UEIC), sold 125,000 shares of the company's common stock for $703,700 on November 17, 2026. This transaction occurred as UEIC stock has seen a 108% surge over the past year, with InvestingPro analysis suggesting it remains undervalued. Following the sale, Mr. Chahil indirectly holds 75,704 shares through a trust.

Which Monthly Check Swings the Most? QYLD, PGX and MUB Side by Side

https://247wallst.com/investing/etf/2026/11/18/which-monthly-check-swings-the-most-qyld-pgx-and-mub-side-by-side/
This article compares the monthly distribution volatility of three income ETFs: QYLD, PGX, and MUB, over a two-year period. QYLD showed the highest variation at 18.5% due to its option premium-based payouts, while PGX had moderate swings at 7% from preferred dividends, and MUB was the steadiest at 2.1% from municipal bonds. The author suggests each ETF suits different investor needs based on their tolerance for payment variability and tax considerations.

Humana (HUM) Stock Trending After Hours as CMS Proposes $90B Medicare Anti-Fraud Rule

https://www.benzinga.com/markets/equities/26/11/63417422/humana-shares-slip-after-hours-cms-fraud-rule
Humana (HUM) shares were trending after hours, slipping 0.46% following the Centers for Medicare & Medicaid Services (CMS) proposal of a new anti-fraud rule. This rule, which targets fraud, waste, and abuse across several healthcare programs, could save taxpayers nearly $90 billion over 10 years. For insurers like Humana, the primary change involves stricter Medicare Advantage Risk Adjustment Data Validation audits to recover improper payments.

Why Is AMD Stock Rising Overnight?

https://stocktwits.com/news-articles/markets/equity/why-is-amd-stock-rising-overnight/cNbLtmJR9iB
Advanced Micro Devices (AMD) stock rose overnight due to two key developments. OpenAI announced that its models improved AMD's flagship GPU design efficiency by up to 14%, expediting chip design progress. Additionally, Rockstar Games confirmed the use of AMD's FSR 4 upscaling technology in the highly anticipated "Grand Theft Auto VI," further boosting market sentiment.

ANT, UNH, CRWD, TTWO, AMZN: 5 Trending Stocks Today - Amazon.com (NASDAQ:AMZN)

https://www.benzinga.com/markets/equities/26/11/63416815/anthropic-unitedhealth-group-crowdstrike-take-two-interactive-and-amazon-why-these-5-stocks-are-on-investors-radars-today
On Wednesday, U.S. stocks had a mixed session as investors reacted to Federal Reserve minutes suggesting potential interest-rate increases. Five stocks, including Anthropic, UnitedHealth Group, CrowdStrike, Take-Two Interactive, and Amazon, gained significant attention. Anthropic saw buzz ahead of its IPO, UnitedHealth Group declined due to calls for healthcare conglomerate breakups, and CrowdStrike rose on strong tech performance and analyst updates. Take-Two Interactive garnered interest from "Grand Theft Auto VI" reviews, while Amazon benefited from its stake in Anthropic.
Advertisement

Humana Drops 6.4% Amid Sector-Wide Selling

https://news.alphastreet.com/humana-drops-6-4-amid-sector-wide-selling/
Humana Inc. shares fell 6.4% to $415.14, caught in a broad sector-wide selloff affecting managed care and health insurance stocks. The decline was not company-specific, as peers like UnitedHealth Group and Elevance Health also saw significant drops, suggesting broader market concerns rather than individual company issues. Despite the sharp decline, analyst sentiment remains constructive with no recent price target cuts, indicating that Wall Street's view of Humana's fundamentals has not materially shifted.

Cytokinetics chief legal officer sells $794,877 in shares

https://www.investing.com/news/insider-trading-news/cytokinetics-chief-legal-officer-sells-794877-in-shares-93CH-5037388
Jeffrey Hessekiel, Cytokinetics' Chief Legal & Admin Officer, sold 15,106 shares of the company's common stock for $794,877 to cover tax withholding obligations. This "sell to cover" transaction was mandated and not discretionary, occurring while the stock trades near its 52-week low. Despite recent strong Q3 2026 financial results, analysts and InvestingPro still consider the stock undervalued with optimistic price targets.

Cintas CEO met with Trump to advance $5 bln UniFirst deal, Semafor reports

https://www.investing.com/news/stock-market-news/cintas-ceo-met-with-trump-to-advance-5-bln-unifirst-deal-semafor-reports-93CH-5037422
Cintas CEO Scott Farmer reportedly met with President Trump to push for the $5 billion acquisition of UniFirst, a deal that would merge two major workwear and facility services providers. Semafor previously reported that FTC Chair Andrew Ferguson is inclined to block the deal, a decision Trump indicated he would respect. Cintas has been pursuing UniFirst since 2022.

Abrams Capital Management sells $182.85M in Loar Holdings stock

https://www.investing.com/news/insider-trading-news/abrams-capital-management-sells-18285m-in-loar-holdings-stock-93CH-5037241
Abrams Capital Management, a 10% owner and director of Loar Holdings Inc. (LOAR), recently sold approximately $182.85 million worth of common stock over two days in mid-November. Following these transactions, the firm still beneficially owns over 29 million shares, held indirectly through various affiliated funds. Concurrently, Loar Holdings reported strong third-quarter revenue, exceeding expectations and leading to an upward revision of its full-year outlook, with Jefferies raising its price target on the stock.

Richard Schwartz, Rush Street Interactive CEO, sells $1.79M in stock

https://www.investing.com/news/insider-trading-news/richard-schwartz-rush-street-interactive-ceo-sells-179m-in-stock-93CH-5037380
Richard Schwartz, CEO of Rush Street Interactive (NASDAQ:RSI), sold 152,842 shares of Class A Common Stock for approximately $1.79 million on November 16, 2026. This sale occurred while the stock was trading near its 52-week low after a 58% decline over six months. The transactions were part of a pre-arranged 10b5-1 trading plan and involved shares held directly by Schwartz and indirectly through trusts.
Advertisement

Healthcare stocks (UnitedHealth, Humana, CVS, Cigna) fall on new Medicare rules

https://beinsure.com/news/healthcare-stocks-fall-as-medicare-rules-trigger-a-selloff/
Shares of major healthcare insurers like UnitedHealth, Humana, CVS Health, and Cigna Group dropped following new Medicare rules proposed by the Centers for Medicare & Medicaid Services (CMS). These stricter oversight measures, particularly expanded Medicare Advantage audits and retrospective payment recoveries, raised concerns about future profitability, with CMS estimating potential federal budget savings of nearly $90 billion. While investment banks maintain generally positive price targets, the selloff highlights investor apprehension regarding regulatory challenges and their impact on earnings.

ProShares Pet Care ETF IOPV (DE000SLA6P91.SG) interactive stock chart

https://uk.finance.yahoo.com/quote/DE000SLA6P91.SG/chart/
This page provides an interactive stock chart for the ProShares Pet Care ETF IOPV (DE000SLA6P91.SG), traded on the Stuttgart exchange. The ETF is currently priced at 55.00 EUR, showing no change as of November 18 at 22:29:50 CET. The article also includes related market news and trending indicators.

Humana Drops 8.5% Intraday: What the Selloff Looks Like

https://247wallst.com/cards/humana-hum-enriched-price-move-01m7qspcf47h9gpxahnbh3ja0t
Humana (HUM) experienced an 8.5% intraday drop, falling from its $441.37 open to stabilize in the low $400s, an unusually sharp move for a large managed-care insurer. Competitor Clover Health (CLOV) also fell by 7.2%, suggesting an industry-wide event rather than company-specific news. Investors are closely watching whether the $401 intraday low will hold as a support level.

Humana Drops 6.4% Amid Sector-Wide Selling

https://news.alphastreet.com/humana-drops-6-4-amid-sector-wide-selling/amp/
Humana Inc. shares dropped 6.4% on Wednesday, reflecting a broad sector-wide selloff that impacted managed care and health insurance stocks like UnitedHealth Group, Elevance Health, Centene, Molina Healthcare, and Clover Health. The decline was not company-specific, suggesting broader concerns about the healthcare coverage sector rather than Humana's fundamentals. Despite the drop, analyst sentiment remains constructive, with no recent price target cuts.

Molina Healthcare Drops 5.9% Amid Sector-Wide Selling

https://news.alphastreet.com/molina-healthcare-drops-5-9-amid-sector-wide-selling/amp/
Molina Healthcare's stock fell 5.9% on Wednesday, closing at $208.22, as part of a broad selloff impacting managed care companies. Major competitors like UnitedHealth Group, Humana, Centene, Elevance Health, and Clover Health also experienced significant declines, indicating a sector-wide retreat rather than company-specific issues for Molina. The synchronized drop suggests a shift in investor sentiment regarding the managed care industry's outlook or risk profile.
Advertisement

Should You Buy, Sell or Hold Ethereum Before Year-End?

https://247wallst.com/investing/cryptocurrency/2026/11/18/should-you-buy-sell-or-hold-ethereum-before-year-end/
Ethereum is currently trading at $1,773, significantly down from its August 2025 high, leading investors to question whether to buy, sell, or hold before year-end. While BitMine Immersion Technologies is aggressively increasing its ETH holdings and staking most of it, sustained outflows from Ethereum funds and a postponed upgrade are bearish indicators. For most investors, holding appears to be the most prudent option to avoid locking in losses, though tax-loss harvesting could make selling attractive for some.

Few payers are ready for looming electronic prior authorization deadline

https://www.techtarget.com/healthcarepayers/news/366654651/Few-payers-are-ready-for-looming-electronic-prior-authorization-deadline
A new survey by the Workgroup for Electronic Data Interchange (WEDI) reveals that only 1 in 10 payers are fully prepared to implement the electronic prior authorization requirements mandated by a 2024 regulation, despite a January 1 deadline. Payers are facing significant challenges with system connectivity, workflow adaptation, and higher-than-anticipated costs for compliance with the API requirements. While most payers are at least halfway there, providers are also largely unprepared, highlighting the complexity and cost of the new interoperability rules.

UnitedHealth, Humana and Elevance fall sharply after Medicare audit proposal

https://www.quantisnow.com/articles/cms-audit-proposal-drives-humana-unitedhealth-and-elevance-lower-as-s-p-500-edges-up
UnitedHealth, Humana, and Elevance Health experienced significant stock declines following a CMS proposal to extend Medicare Advantage audit recoveries back to 2018. The proposal, which could amount to roughly $9 billion per payment year, led to a combined paper loss of about $43 billion for the three companies by early afternoon on November 18, 2026. Analysts expect potential legal challenges to the rule, with Oppenheimer suggesting recoveries may be concentrated later and priced into future bids.

UnitedHealth and Humana fall after CMS proposes a $90 billion anti-fraud rule

https://mlq.ai/news/unitedhealth-and-humana-fall-after-cms-proposes-a-90-billion-anti-fraud-rule/
Shares of UnitedHealth Group, Humana, CVS Health, and Cigna fell after the Centers for Medicare & Medicaid Services (CMS) proposed a new Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) rule. This rule aims to recover an estimated $90 billion over 10 years through tougher audits of Medicare Advantage insurers, extrapolating audit findings and requiring reporting of suspected fraud. The proposal, scheduled for publication on November 19, 2026, is open for comments until January 19, 2027, and follows a previous court setback for similar provisions.

Quanterix Corporation FY26 Results: Sales guidance affirmed at $142M-$146M

https://scanx.trade/stock-market-news/companies/quanterix-corporation-fy26-results-sales-guidance-affirmed-142m-146m/56555447
Quanterix Corporation has reaffirmed its full-year fiscal 2026 sales guidance, projecting revenue between $142 million and $146 million, which aligns closely with the analyst consensus of $143.357 million. This steady forecast indicates the company's confidence in its current operational trends and a cautious revenue trajectory for the upcoming fiscal year. The guidance suggests stable expectations, with the analyst estimate falling within the lower half of the company's projected range.
Advertisement

ConocoPhillips Stock (COP) Moved Down by 3.11% on Nov 18: What Signal Does It Send?

https://www.tradingkey.com/news/market-movers/262311573-market-movers-cop-20261118
ConocoPhillips (COP) stock declined by 3.11% due to falling crude oil benchmarks, softening global demand, and institutional de-risking from energy holdings. The company's pure-play exploration and production model makes it highly sensitive to commodity price fluctuations, further exacerbated by rising inventories and supply concerns. Technical indicators show a neutral MACD and RSI, with Williams %R suggesting a sell condition, while fundamental analysis highlights its strong revenue and profit within the Energy - Fossil Fuels industry.

Molina Healthcare of Illinois Commits $2.4 Million to Expand Access to Care Across the State

https://www.businesswire.com/news/home/20261118317751/en/Molina-Healthcare-of-Illinois-Commits-%242.4-Million-to-Expand-Access-to-Care-Across-the-State
Molina Healthcare of Illinois, in partnership with The MolinaCares Accord, is investing $2.4 million into over 20 community-based organizations to enhance health outcomes and expand access to care for Illinois residents. This investment focuses on critical areas such as maternal health, behavioral health, and addressing health-related social needs, bringing Molina's total community investment in Illinois to over $7.4 million since 2023. The grants support community-led solutions, including services for pregnant individuals, mental health support for youth, and resources for food insecurity and housing stability.

Dow Drops 475 Points On Losses For UnitedHealth, Chevron Shares

https://www.moomoo.com/news/post/1005067481/dow-drops-475-points-on-losses-for-unitedhealth-chevron-shares
The Dow Jones Industrial Average dropped 475 points due to significant losses in UnitedHealth and Chevron shares. This decline reflects broader market concerns impacting major industrial components. Investors are reacting to specific company performance and overall economic sentiment.

Josh Brown Says Netflix Trades at 16 Times Next Year's Earnings After a 50% Drop. Is It a Buy?

https://247wallst.com/investing/2026/11/18/josh-brown-says-netflix-trades-at-16-times-next-years-earnings-after-a-50-drop-is-it-a-buy/
Josh Brown, CEO of Ritholtz Wealth Management, notes that Netflix (NFLX) is trading at 16 times next year's earnings estimates after a 50% decline from its high. Despite a strong Q3 performance with expanded operating margins and a record share buyback, factors like slower ad rollouts, cooling U.S. growth, and falling Q4 estimates contribute to its discounted valuation. The stock's future re-rating depends on the timely execution of ad strategies and the production of new original content hits.

Plug Power Rallies 6% After Fuel Cell Selloff; FuelCell Dips, Bloom Energy Holds Steady

https://247wallst.com/investing/2026/11/18/plug-power-rallies-6-after-fuel-cell-selloff-fuelcell-dips-bloom-energy-holds-steady/
Plug Power (NASDAQ:PLUG) stock rallied 6% to $1.11 after a recent fuel cell selloff, despite still being down 43% year-to-date. The company's Q3 2026 revenue beat expectations, and gross margin improved significantly, though profit was flattered by non-cash gains. Meanwhile, FuelCell Energy (NASDAQ:FCEL) saw a slight dip but remains up 12% YTD, and Bloom Energy (NYSE:BE) held steady, up 100% YTD, benefiting from its larger scale and profitability.
Advertisement

Wafd stock hits 52-week low at 28.1 USD

https://www.investing.com/news/company-news/wafd-stock-hits-52week-low-at-281-usd-93CH-5036629
WaFd Inc.'s stock has fallen to a 52-week low of $28.10, reflecting decreased investor confidence and a 9.76% decline over the past year. Despite this, InvestingPro analysis suggests the stock is undervalued with a P/E ratio of 8.82 and a PEG ratio of 0.4, indicating potential for near-term earnings growth. The company also maintains a consistent dividend payment history for 44 consecutive years, offering a 3.82% yield.

Why Microsoft Could Surprise and Hit $4 Trillion Before NVIDIA Does

https://247wallst.com/investing/2026/11/18/why-microsoft-could-surprise-and-hit-4-trillion-before-nvidia-does/
Microsoft and NVIDIA are both nearing a $4 trillion market capitalization, with their values currently around $3.75 trillion. The article suggests Microsoft might reach this milestone first due to its robust, diversified business operations and a significant $677 billion backlog that is not dependent on immediate chip orders. While NVIDIA boasts faster growth and innovative hardware like Vera Rubin systems, its higher stock volatility and reliance on a few major customers introduce more risk, potentially giving Microsoft a quieter, more stable path to the $4 trillion valuation.

Unitedhealthcare Partners With Independent Pharmacies for Telehealth and Testing

https://www.benzinga.com/news/health-care/26/11/63393175/unitedhealthcare-partners-with-independent-pharmacies-for-telehealth-and-testing
UnitedHealthcare, a unit of UnitedHealth Group Inc. (NYSE:UNH), has partnered with CPESN USA to launch a new care delivery model leveraging independent pharmacies for telehealth and testing services. This initiative aims to expand access to high-quality healthcare, especially in rural and underserved communities, by utilizing pharmacists as local access points. The program connects members with virtual care providers, offers point-of-care testing, and provides personalized health support to close care gaps and improve coordination.

Dow Drops 600 Points On Losses In Shares Of UnitedHealth, Chevron

https://www.moomoo.com/news/post/1005062151/dow-drops-600-points-on-losses-in-shares-of-unitedhealth
The Dow Jones Industrial Average fell 600 points due to significant losses in the shares of UnitedHealth and Chevron. This decline indicates a notable downturn in the market driven by these major components of the index.

Unitedhealth Group Inc Stock (UNH) Moved Down by 4.61% on Nov 18: Key Drivers Unveiled

https://www.tradingkey.com/news/market-movers/262311282-market-movers-unh-20261118
UnitedHealth Group Inc. (UNH) experienced a 4.61% drop in stock price due to intensified regulatory scrutiny, particularly proposed federal oversight initiatives from the Centers for Medicare and Medicaid Services (CMS) aiming to curb healthcare waste and expand risk-adjustment audits, which could lead to significant retroactive recoveries. Additionally, renewed political scrutiny on vertical integration in healthcare, especially concerning health insurers controlling pharmacy benefit managers and providers, added to operational risk. Persistent industry-wide operational pressures like elevated medical utilization and compressed underwriting spreads further dampened market sentiment.
Advertisement

CVS Health Raised Its 2026 Outlook 3 Times, but Not Its Dividend

https://247wallst.com/investing/2026/11/18/cvs-health-raised-its-2026-outlook-3-times-but-not-its-dividend/
CVS Health has maintained its dividend at $0.665 per share for 12 consecutive quarters despite raising its 2026 guidance three times, now expecting at least $8.20 adjusted EPS and $15.5 billion in operating cash flow. The company prioritizes share buybacks and a planned split into two public companies by the first half of 2028, with debt reduction achieved ahead of schedule. While financially capable of a dividend increase, strategic priorities currently take precedence, though Aetna's improved medical benefit ratio strengthens the long-term case.

Florida Seniors and Primary Care Providers Agree that Prevention, Affordable Care and Comprehensive Coverage are Keys to Healthy Aging

https://www.quantisnow.com/insight/florida-seniors-and-primary-care-providers-agree-that-prevention-affordable-6798307
Humana commissioned two Morning Consult surveys of Florida seniors and primary care providers, highlighting affordability, prevention, supplemental benefits, and coordinated care as top priorities for healthy aging. The surveys suggest strong retention for Medicare Advantage plans, with 97% of current enrollees planning to stay. However, both providers and seniors identified out-of-pocket and prescription drug costs as significant barriers.

A 70-Year-Old Who Bought 1,000 Berkshire Shares at the May 2025 Peak Waited 17 Months to Break Even

https://247wallst.com/investing/2026/11/18/a-70-year-old-who-bought-1000-berkshire-shares-at-the-may-2025-peak-waited-17-months-to-break-even/
This article details the financial experience of a 70-year-old who purchased 1,000 Berkshire Hathaway Class B shares at their May 2025 peak and waited 17 months to break even. It examines the tax implications of selling a portion of the shares now that they are profitable, considering different income scenarios and the impact of the net investment income tax. The piece also highlights how the company's performance and dividend policy affected the investor during this period and the changes under the new CEO, Greg Abel.

Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana, Centene and Molina

https://www.theglobeandmail.com/investing/markets/stocks/UNH/pressreleases/8894263/zacks-industry-outlook-highlights-unitedhealth-the-cigna-humana-centene-and-molina/
The U.S. health insurance (HMO) industry faces both opportunities and challenges, with diversified health plans and an aging population supporting membership and demand for Medicare. Regulatory changes like Medicaid eligibility checks and expired ACA subsidies threaten enrollment, while technological advancements like AI and telehealth improve efficiency but carry implementation costs. Industry leaders like UnitedHealth Group, Cigna, Humana, Centene, and Molina Healthcare are well-positioned to leverage these dynamics, supported by strategic acquisitions and an optimistic Zacks Industry Rank.

TNL Mediagene regains Nasdaq compliance after asset sale

https://www.investing.com/news/company-news/tnl-mediagene-regains-nasdaq-compliance-after-asset-sale-93CH-5035549
TNL Mediagene (NASDAQ:TNMG) has regained compliance with Nasdaq's minimum stockholders' equity requirement following the sale of its Japanese operating subsidiaries. The company will be subject to a one-year Mandatory Panel Monitor, during which any new non-compliance with the equity rule will result in a delisting determination without further opportunity for a compliance plan. TNL Mediagene is a Taipei-headquartered technology and digital media company.
Advertisement

TJX COMPANIES INC (NYSE:TJX): A Quality Investing Standout in Off-Price Retail

https://www.chartmill.com/news/TJX/Chartmill-58867-TJX-COMPANIES-INC-NYSETJX-A-Quality-Investing-Standout-in-Off-Price-Retail
This article highlights TJX Companies (NYSE:TJX) as a strong quality investing candidate based on its ability to grow revenue and operating profit, achieve high returns on invested capital, manage debt effectively, and convert accounting profit into cash. The company passes the "Caviar Cruise" framework's demanding thresholds for revenue and EBIT growth, ROIC, debt-to-free cash flow, and profit quality. While valuation is not its strongest point, its durability and consistent returns make it attractive for quality-focused investors.

PACE Organization InnovAge Agrees to Pay $36M to Resolve False Claims Act Allegations

https://finchannel.com/pace-organization-innovage-agrees-to-pay-36m-to-resolve-false-claims-act-allegations/142050/health-beauty/2026/11/
InnovAge Holding Corporation has agreed to pay $36 million to settle allegations that it violated the False Claims Act and state laws. The company is accused of failing to provide comprehensive medical services and timely specialist referrals to its elderly patients enrolled in the PACE program. This settlement highlights the government's commitment to holding PACE organizations accountable for the care of vulnerable seniors.

UnitedHealth Shares Slide 5.4% Amid Scrutiny Over Conglomerate Structure and Medicare Oversight

https://news.jkn.co.kr/editions/english/post/1103124
UnitedHealth Group Inc. shares dropped 5.42% following renewed calls from Senator Elizabeth Warren to break up major healthcare conglomerates with the proposed Break Up Big Medicine Act. This legislative push, coupled with the Centers for Medicare & Medicaid Services proposing the CRUSH rule to tighten Medicare Advantage regulations, intensified scrutiny on UnitedHealth's integrated business model. Despite strong third-quarter earnings, the company's stock underperformed the market.

Novo expands DTC program Novocare to support Wegovy users through holistic health journey

https://www.fiercepharma.com/marketing/novo-expands-dtc-program-novocare-support-wegovy-users-through-holistic-health-journey
Novo Nordisk has rebranded its direct-to-patient pharmacy, NovoCare, to offer expanded services for Wegovy users, moving beyond just prescriptions to provide holistic health support. The program now includes treatment information, coaching, progress tracking, and partnerships with brands like Whoop and Stitch Fix to aid in lifestyle changes. NovoCare aims to be a comprehensive hub for patients and healthcare professionals, ensuring access to authentic medication and resources for navigating weight loss journeys.

Amylyx Pharmaceuticals (AMLX) Stock Price, Chart & Analysis

https://www.debelegger.nl/en/stock/AMLX.US
This article provides a detailed analysis of Amylyx Pharmaceuticals (AMLX) stock, including its latest price, market capitalization, and key financial figures. It covers valuation metrics, growth prospects, margins, debt status, and dividend policy, noting that the company currently pays no dividend. The article also includes analyst forecasts and price targets for the stock.
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement